Research has been currently made to increase the yield, efficiency and to decrease the timing, cost of these highly wanted drugs. Several promoters, catalysts and surfactants have been employed in this regard. The most common precursor viz., o-Phenyline diamine and their substituted derivatives are known. In general, quinoxalines are synthesized by the simple condensation of Naphthalene 2, 3-diamines with benzil compounds by the formation of C-C and carbon-heteroatom 1 using CTAB as the surfactant. This is one of the well known ways for developing green synthetic routes. 1, 2-diketones appear frequently as substituted by condensation of aryl-1, 2-diamines with benzil compounds.
The preparation of Quinoxaline by the reaction of benzils and their derivatives with Naphthalene based diamines uses surfactant property and hence, CTAB was considered as the surfactant medium for the reaction 2 . In order to find other competing catalyst that may be better than CTAB, in this paper, we compared the efficiency of the same synthesis with that of the polymer supported sulphanilic acid 3 . The resulting quinoxaline products were verified for their biological applications such as anxiolytic, sedative and hypnotic activities on mice.
MATERIALS ANd ExpERIMENTAL METHOdS

Chemistry
Melting point of the resulting products were determined using a capillary in a melting point apparatus (Toshiba) and are noted as such. The FTIR Spectra were recorded on a Perkin Elmer Spectrum1 FT-IR instrument with the resolution of 1.0 cm -1 using the KBr disc in the range of 4000-400 cm -1 . The PMR and CMR spectra were measured on a Bruker Advance III instrument (600 and 150 MHz, respectively) using a solvent signal as the reference. The units of Chemical shifts (d) are given in ppm and coupling constants (J) in Hz. Assignments of signals in CMR spectra were made on the basis of the HMQC experiments. Both 2,3-diaminonapthalene (99.9%), 1,2-diketones (99.8%) were obtained from SigmaAldrich, India and were used as such without further purification. 1,2-diketone was used in three different forms namely, benzil, 4,4'-dimethylbenzil and 4,4'-diflurobenzil for the purpose of finding the substituent effect. CTAB was used as the cationic surfactant. A mixture of 1M HCl and Ethanol-spirit was used as the solvent. After the reaction completion (which was completely monitored by TLC), the synthesized product was precipitated by using Ethanol. Surfactant (CTAB) was left in the solvent without further actions.
procedure for the synthesis of derivatives
In a 100 ml beaker, 2 mmol of Benzil, 2 mmol of CTAB were added to 10 ml Ethanol and placed on a magnetic stirrer cum temperature bath at stirring speed of 750 rpm at 35 0 C, a little higher than room temperature. A mixture of 10 ml of 2, 3-diaminonapthalene dissolved in 1M HCl was added in-situ to this reaction mixture drop by drop. A pale brown coloured precipitate was obtained after 10 minutes. The precipitate was filtered using Whatmann 40 filter paper and subsequently dried under shadow. The precipitate was re-crystallized with ethanol. This re-crystallized yield was used as a source for further TLC and HPLC chromatographic studies followed by spectroscopic characterization. The structure of the resulting compound was as shown in the Figure 1 .
procedure for the synthesis of 2, 3-diphenyl benzo [g] quinoxaline
In a 100 ml beaker, 2 mmol of 1,2-diphenylethane-benzil, 2 mmol of CTAB were added to 10 ml Ethanol and placed on magnetic stirrer, added with 2 mmol of 2,3-diaminonaphthalene in 10 ml 1M HCl, in-situ to this reaction mixture, drop by drop. The precipitate was re-crystallized with ethanol. In a 100 ml beaker, 2 mmol of 4,4'-dimethylbenzil, 2 mmol of CTAB were added to 10 ml Ethanol and placed on magnetic stirrer, added with 2 mmol of 2,3-diaminoNapthalene in 10ml 1M HCl, in-situ to this reaction mixture, drop by drop. The precipitate was re-crystallized with Ethanol. 
procedure for the synthesis of 2, 3-bis(4-fluorophenyl)benzo[g]quinoxaline
In a 100 ml beaker, 2 mmol of 4,4'-difluorobenzil, 2 mmol of CTAB were added to 10 ml Ethanol and placed on magnetic stirrer, added with 2 mmol of 2,3-diaminoNapthalene in 10 ml 1M HCl, in-situ to this reaction mixture, drop by drop. The precipitate was re-crystallized with Ethanol. 
pharmacology
Animal subject used
Swiss albino mice of male gender (21-24 g) were used throughout the study. They were provided normal pellet diet and drinking water ad libitum and were exposed to 12 h sunlight and 12 h dark cycle. The animals were made physiologically responsive to the laboratory conditions prior to the experiments. Animals' care was taken as per guidelines of the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Environment and Forests Ministry, India.
drugs used
Diazepam hydrochlor ide (Ranbaxy Laboratories, Gurgaon, India) was procured and used as a standard drug and it was diluted with saline water to the needed strength prior to the use. The test compounds were suspended in 0.3% w/v of sodium carboxymethyl cellulose (CMC) and were administered through oral gavage.
Acute Toxicity Studies
Acute Oral Toxicity (AOT 423) guideline was followed for the acute toxicity studies of the synthesized compounds. Briefly, overnight fasted animals were treated with various concentrations of the compounds to be tested (5, 50, 300 and 2000 mg/kg, bw) by oral route. The observation of animals for any behavioral changes or mortality for first 24 h was done. The animals were maintained for another 14 days to check the abnormal changes and mortality. Based on the results, the dose was fixed for pharmacological studies.
Anxiolytic activity Elevated plus Maze (EpM) Test
To assess the anti-anxiety activity of test compounds, elevated plus maze (EPM) was used 
procedure
Animals were divided in to 11 groups, each 6 in a group. The Group I served as control served with vehicle, Group II served as standard served with diazepam at the dose of 0.5mg/kg. Group III -XI the animals were treated with the compounds to be tested at the dose of (5 mg/kg, bw, p.o). The compounds were administered through oral way using a tuberculin syringe fitted with oral canula. The drug administration schedule was adjusted so that each mouse was having its turn on the EPM apparatus 45 minutes after the administration of the dose. During the complete experiment, all the animals were allowed to socialize. Every care was taken to make sure that no external stimuli, other than the height of plus-maze could invoke anxiety in the animals. The parameters noted is (a). Time spent in open arm and (b). Number of arm entries to assess the anxiolytic activity.
Sedative and Hypnotic activity Hole -board Test
In order to examine the sedative and hypnotic activity of the synthesized compounds, Hole-Board Test was performed. The Hole-board apparatus is set to comprise a grey Perspex panel (40×40 cm, 2.2 cm thick) with 16 equidistant holes (diameter of 3 cm) in the floor. Photocells below the surface of the holes have given way for the measure of the number of head dips. The board was placed 15 cm above the table and it was divided with black water-resistant marker into 9 squares of 10×10 cm. 30 minutes after the introduction of the test drug; each mouse was separately placed in the centre of the board. During these 5 minutes of test period, number of head dips was observed.
procedure
Animals were broadly divided in to eleven groups, each 6 in a group. The Group I served as control served with the vehicle, Group II served as standard served with diazepam drug at the dose of 3 mg/kg. Group III -XI the animals were treated with the test compounds at the dose of (5 mg/kg, bw, p.o). The compounds to be tested were introduced orally using a tuberculin syringe fitted with oral canula. After 45 minutes of oral administration of the test compounds, the animals were placed in to the center of the perforated board and noted for the period of 5 minutes and the number of head exploration was counted in order to find out the sedative and hypnotic activity.
Locomotor activity
To evaluate the spontaneous locomotor activity of the synthesized compounds, actophotometer was used. Actophotometer (Popular Traders, Ambala, India) was utilized for the present study. Mice were placed separately in activity cage for 5 minutes test period, 45 minutes after the introduction of test drugs. Locomotor activity was noted in terms of the activity scores.
procedure
Animals were divided in to 11 groups, each group consists of 6 animals. The Group I served as control served with vehicle, Group II animals served as standard which receives diazepam at the dose of 3 mg/kg, through intra-peritoneal route. Group III -XI the animals were treated with the test compounds at the dose of (5 mg/kg, bw, p.o). The test compounds were administered orally by the use of a tuberculin syringe fitted with oral canula. After 45 minutes of oral introduction of the various fractions the animals were placed in to the actophotometer. Movement of the animal is recorded by the light beams present inside the actophotometer for the evaluation of the locomotor activity.
RESULTS ANd dISCUSSION
Synthesis and Characterizations
Condensation of 2, 3-diaminonapthalene with benzil was employed as the key reaction. The T h e m e t h o d fo r t h e s y n t h e s i s o f 2-substitute benzothiazoles from the reaction of 2-aminothiophenol with aldehyde catalysed by CTAB in water 5 was followed. One step synthesis of mesoporous material was achieved by adopting the double templates consisting of the conventional cation hyamine surfactant CTAB
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.
Acute Toxicity Studies
Oral toxicity study for the test compounds were determined as per AOT 423 guidelines. Two out of three animals were died in the group of animals treated with 300 mg/kg, bw, hence the preceding dose was considered as LD50 dose. A dilute quantity of drug i.e., one tenth of the dose(5 mg/kg, bw) was used for further studies. . Some simple 2,3-quinoxaline diones containing +I and -I groups and two quinoxalinone only one carbonyl functional group has synthesized and screened for neuro-pharmacological activity in mice and rats
9
. Only the c hloro-functional group at position 6 and N, N-dibenzylsulphonamido group are essential for neuro-production against the induced seizers, in addition to the observed good activity of the dibenzylsulfonamido quinoxaline diones.
The time spent by the animals in the open arms treated with standard drug diazepam and test compounds was significantly increased when compared to the control group which was treated with the same volume of vehicle. Among the test compounds, all the three substituted quinoxaline series showed significant anxiolytic activity, which shows mild to moderate activity. These compounds show a little difference when compared to the standard drug which indicates that the compounds are equipotent anxiolytic to the standard diazepam. The results are depicted in the figures 2a and 2b.
It can be observed from the Figure 2a that the time spent in open arm is increased nearer to the standard diazepam. Using the Figure 2b , the gradual increase in number of arm entries based on the potency of the individual test compounds, can be witnessed. It should be noted that the increase in open arm entry data is the most important index of anxiolytic activity. Time spent on the central platform appears to be relevant to decision making process and risk assessment process, further, the total arm entries is the direct measure reflecting the changes in anxiety. The enhanced activity of the quinoxaline drug and its derivatives is expected to be due to the binding site of the ion channel receptor present in the CNS. This in turn, would stimulate the binding of GABA A subunit with the GABA receptor, which would produce the prolongation of opening of the channels of chloride ion. The prolonged opening leads to mild hyper polarization which may be responsible for the noted anxiolytic activity of the test compounds. Quinoxalines act not just by substituting for GABA A , which bind at the á-subunit, but also increase the number of channel opening events, which leads to an increase in conductance of Chloride ion and also inhibition of the action potential
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Sedative and Hypnotic activity
The hole-board test used to assess the sedative and hypnotic potential of the test compounds. This test confirmed the CNS calming nature of the test compounds. The results are shown in the Figure 3 . The number of hole explore was counted for the period of 5 minutes and the results revealed that the control animal was active whereas the head exploration has been largely reduced in the animals treated with the standard diazepam drug at the dose of 4 mg/kg. The test compounds possess various degree of hole exploration values. Diazepam is the CNS depressant used in the management of sleep disorders such as insomnia; these drugs have a binding site on GABA receptor type-A ionophore complex (GABA A ). The drug decreases activity, moderates excitement and calms the nerve recipient. GABAergic pathway, since its transmission can produce profound sleeping in mice. The ordinary inhibitory action of GABA consists in the opening of chloride channels to allow hyperpolarizing the membrane, leading to CNS depression and results in sedative and hypnotic activity. Glutamate and GABA are quantitatively the most representative excitatory and inhibitory neurotransmitters, respectively, in the mammalian brain. Thus, receptors for these two neurotransmitters are regarded as usual and essential targets for psychotropic drugs. The activity of the compound to be tested may be due to binding with these receptors.
Locomotor activity
The mean score in locomotor activity, before and after the treatment were measured and are shown in the Figure 4 . There are notable difference observed in the mean score before treatment with standard and the test compounds. After the standard/test drug treatment, the mean score for the diazepam treated group and the test Quinoxaline derivatives treated, together appear lesser active, when compared to the control group. But the test compounds were observed to show worthier statistics when compared to the standard drug. The results revealed the significant reduction in locomotor activity by the quinoxaline based derivatives. Locomotor activity is believed as an index of alertness and a reduction in that is an indicative of sedative activity. GABA is the important inhibitory neurotransmitter in the CNS and different anxiolytic, muscle relaxant and sedativehypnotic drugs are expected to exhibit their action through GABA. Therefore, it is possible that the test compounds may act by direct activation of GABA receptors by the test compounds. The increase in efficiency of the natural brain chemical, GABA A , by the quinoxaline based derivative is achieved along with the decrease in excitability of neurons.
CONCLUSIONS
Naphthalene based Quinoxalines were successfully synthesized with greater yield (96%) and shorter duration (5 minutes) using CTAB as the surfactant. The synthesis in the absence of cationic surfactant resulted in poor yield and time consuming (35% and 90 min). The solubility of this compound in ethanol, suggests that this product can be used as a challenging drug for the pathogens. The synthesis of naphthalene-quinoxaline by this method produced no harmful emissions. These provide a very good option for non-toxic drug possessing anxiolytic, sedative and hypnotic properties. When compared with benzodiazepine drugs, these naphthalene based quinoxaline drugs shows a little lower effective as an anxiolytic drug and better effect as a sedative and hypnotic. 
